prednisolone has been researched along with Osteoporosis, Postmenopausal in 14 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| " administration of disodium pamidronate can effectively achieve primary prevention of glucocorticoid-induced osteoporosis (GIOP)." | 9.08 | Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial. ( Boutsen, Y; Devogelaer, JP; Esselinckx, W; Jamart, J; Stoffel, M, 1997) |
| "We describe the case of a patient who developed reversible retrobulbar optic neuritis after intravenous pamidronate therapy for established osteoporosis." | 7.69 | Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria. ( Body, JJ; des Grottes, JM; Dumon, JC; Schrooyen, M, 1997) |
| " administration of disodium pamidronate can effectively achieve primary prevention of glucocorticoid-induced osteoporosis (GIOP)." | 5.08 | Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial. ( Boutsen, Y; Devogelaer, JP; Esselinckx, W; Jamart, J; Stoffel, M, 1997) |
| "To ascertain changes in axial bone mineral in premenopausal women with severe rheumatoid arthritis (RA) treated with and without prednisolone (PRED), we conducted a two-year follow-up study of axial bone mineral density (BMD) and bone mineral content (BMC)." | 3.74 | Changes in bone mineral density in premenopausal women with rheumatoid arthritis during a two-year follow-up. ( Hakala, M; Hämäläinen, H; Järvenpää, S; Kaarela, K; Kauppi, M; Kotaniemi, A; Kröger, H, 2007) |
| "We describe the case of a patient who developed reversible retrobulbar optic neuritis after intravenous pamidronate therapy for established osteoporosis." | 3.69 | Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria. ( Body, JJ; des Grottes, JM; Dumon, JC; Schrooyen, M, 1997) |
| "Mild anterior uveitis is an unfamiliar adverse effect of pamidronate therapy." | 1.34 | Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost. ( Palimar, P; Quah, S; Ramasamy, B; Sahni, JN, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tamborrini, G | 1 |
| Moser, F | 1 |
| Sterki Novakova, K | 1 |
| Paggiosi, MA | 1 |
| Peel, NF | 1 |
| Eastell, R | 1 |
| Miyanishi, K | 1 |
| Hara, T | 1 |
| Hamada, T | 1 |
| Maekawa, M | 1 |
| Tsurusaki, S | 1 |
| Moro-oka, TA | 1 |
| Kamo, Y | 1 |
| Jingushi, S | 1 |
| Torisu, T | 1 |
| Belliveau, MJ | 1 |
| Almeida, DR | 1 |
| Urton, TE | 1 |
| Ramasamy, B | 1 |
| Quah, S | 1 |
| Sahni, JN | 1 |
| Palimar, P | 1 |
| Hämäläinen, H | 1 |
| Kaarela, K | 1 |
| Kröger, H | 1 |
| Kauppi, M | 1 |
| Järvenpää, S | 1 |
| Hakala, M | 1 |
| Kotaniemi, A | 1 |
| Katayama, K | 1 |
| Matsuno, T | 1 |
| Kaji, H | 1 |
| Yamauchi, M | 1 |
| Chihara, K | 1 |
| Sugimoto, T | 1 |
| des Grottes, JM | 1 |
| Schrooyen, M | 1 |
| Dumon, JC | 1 |
| Body, JJ | 1 |
| Boutsen, Y | 1 |
| Jamart, J | 1 |
| Esselinckx, W | 1 |
| Stoffel, M | 1 |
| Devogelaer, JP | 1 |
| Pearce, G | 1 |
| Ryan, PF | 1 |
| Delmas, PD | 1 |
| Tabensky, DA | 1 |
| Seeman, E | 1 |
| Yilmaz, L | 1 |
| Ozoran, K | 1 |
| Gündüz, OH | 1 |
| Uçan, H | 1 |
| Yücel, M | 1 |
| Gallacher, SJ | 1 |
| Fenner, JA | 1 |
| Anderson, K | 1 |
| Adamson, BB | 1 |
| Banham, SW | 1 |
| Boyle, IT | 1 |
5 trials available for prednisolone and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Effects of bisphosphonates on fracture incidence and bone metabolism in rheumatoid arthritis patients in general practice taking long-term corticosteroid therapy: a retrospective study.
Topics: Aged; Alendronate; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bone and Bones; Bone Density Con | 2008 |
Glucocorticoid excess affects cortical bone geometry in premenopausal, but not postmenopausal, women.
Topics: Administration, Oral; Adult; Cushing Syndrome; Dose-Response Relationship, Drug; Female; Glucocortic | 2008 |
Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial.
Topics: Absorptiometry, Photon; Adult; Aged; Anti-Inflammatory Agents; Biomarkers; Bone Density; Calcium; Di | 1997 |
The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica.
Topics: Aged; Alkaline Phosphatase; Androstenedione; Anti-Inflammatory Agents; Bone and Bones; Bone Density; | 1998 |
Alendronate in rheumatoid arthritis patients treated with methotrexate and glucocorticoids.
Topics: Absorptiometry, Photon; Aged; Alendronate; Arthritis, Rheumatoid; Bone and Bones; Bone Density; Calc | 2001 |
9 other studies available for prednisolone and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Topics: Diphosphonates; Female; Humans; Imidazoles; Middle Aged; Ophthalmic Solutions; Osteoporosis, Postmen | 2018 |
The impact of glucocorticoid therapy on trabecular bone score in older women.
Topics: Absorptiometry, Photon; Aged; Anthropometry; Bone Density; Cross-Sectional Studies; Female; Glucocor | 2015 |
Co-occurrence of subchondral insufficiency fracture of the femoral head and contralateral femoral neck fracture in a rheumatic patient receiving steroid treatment.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diagnosis, Differential; Drug | 2008 |
Acute anterior uveitis following zoledronic acid infusion for osteoporosis.
Topics: Acute Disease; Blood Sedimentation; Bone Density Conservation Agents; C-Reactive Protein; Dexamethas | 2012 |
[The patient suffers from rheumatism for many years. It also makes the bones brittle].
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Diphosphonates; Female; Glucocorticoids; Humans; Ma | 2002 |
Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost.
Topics: Acute Disease; Administration, Topical; Aged, 80 and over; Anti-Inflammatory Agents; Bone Density Co | 2007 |
Changes in bone mineral density in premenopausal women with rheumatoid arthritis during a two-year follow-up.
Topics: Adult; Age of Onset; Arthritis, Rheumatoid; Blood Sedimentation; Bone Density; Female; Follow-Up Stu | 2007 |
Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria.
Topics: Anti-Inflammatory Agents; Diphosphonates; Evoked Potentials, Visual; Female; Humans; Infusions, Intr | 1997 |
Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study.
Topics: Absorptiometry, Photon; Asthma; Bone Density; Female; Humans; Osteoporosis; Osteoporosis, Postmenopa | 1992 |